Skip to content

Comparing Blood-Based Ratios for Predicting Outcomes in Sepsis and Septic Shock

Comparing the Prognostic Value of Neutrophil-lymphocyte Ratio Versus Lactate-albumin Ratio Among Critically Ill Patients in Sepsis and Septic Shock

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07819708
Enrollment
60
Registered
2026-09-15
Start date
2025-10-10
Completion date
2026-09-09
Last updated
2026-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis, Septic Shock

Keywords

Neutrophil-to-lymphocyte ratio, Lactate-to-albumin ratio, 28-day mortality, Prognostic biomarker, Sequential Organ Failure Assessment

Brief summary

Sepsis and septic shock are serious conditions associated with a high risk of organ dysfunction and death. Simple laboratory-based markers may help identify critically ill patients who are at greater risk of poor outcomes. This prospective observational cohort study compared the prognostic value of the neutrophil-to-lymphocyte ratio and the lactate-to-albumin ratio in adult patients with sepsis or septic shock admitted to the Surgical Intensive Care Unit at Benha University Hospital. A total of 60 participants were enrolled and followed for 28 days. The study evaluated the relationship of both laboratory ratios with 28-day mortality and compared their ability to predict mortality. Intensive care unit length of stay and progression of organ dysfunction were also assessed.

Interventions

None listed

Sponsors

Benha University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18 to 60 years with clinically confirmed sepsis or septic shock. * Male and female patients. * Fulfillment of at least two quick Sequential Organ Failure Assessment criteria, including: * Glasgow Coma Scale score less than 15. * Systolic blood pressure less than 100 millimeters of mercury. * Respiratory rate greater than 22 breaths per minute. * Evidence of infection-related organ dysfunction demonstrated by an increase of more than 2 points in the Sequential Organ Failure Assessment score. * Evidence of organ dysfunction, including one or more of the following: * Ratio of arterial partial pressure of oxygen to fraction of inspired oxygen less than 300. * Glasgow Coma Scale score less than 15. * Mean arterial pressure less than 70 millimeters of mercury. * Serum creatinine greater than 1.2 milligrams per deciliter. * Urine output less than 0.5 milliliters per kilogram per hour. * Serum bilirubin greater than 1.2 milligrams per deciliter. * Platelet count less than 150,000 per microliter. * For patients with septic shock, persistent hypotension requiring vasopressors to maintain mean arterial pressure above 65 millimeters of mercury and serum lactate greater than 2 millimoles per liter despite adequate fluid resuscitation. * Ability of the patient or legally authorized representative to provide informed consent.

Exclusion criteria

* Active malignancy or chemotherapy within the previous 3 months. * Corticosteroid therapy within 90 days before admission. * Documented severe liver or kidney dysfunction. * Clinical conditions requiring albumin administration. * Pregnancy or breastfeeding. * Insufficient laboratory data or inability to complete follow-up.

Design outcomes

Primary

MeasureTime frameDescription
28-Day All-Cause MortalityFrom intensive care unit admission through 28 daysThe number and percentage of participants who died from any cause within 28 days after study enrollment.

Secondary

MeasureTime frameDescription
Intensive Care Unit Length of StayFrom intensive care unit admission until intensive care unit discharge or death, assessed through 28 daysThe duration of stay in the intensive care unit was recorded in days for each participant.
Change in Sequential Organ Failure Assessment ScoreAt intensive care unit admission, 6 hours, and 24 hoursThe Sequential Organ Failure Assessment score was used to assess dysfunction across six organ systems: respiratory, cardiovascular, hepatic, coagulation, renal, and neurological. Each organ system is scored from 0 to 4 points according to the degree of dysfunction, giving a total score ranging from 0 to 24 points. Higher scores indicate more severe organ dysfunction. Changes in the Sequential Organ Failure Assessment score during the first 24 hours were evaluated to assess progression of organ dysfunction.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 16, 2026